Keenan, Susan - University of Northern Colorado

个人简介

Ph.D.: Pharmacological and Physiological Sciences, St. Louis University Medical School (1997-2001) B.A.: Chemistry, University of Missouri, St. Louis (1994-1997)

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Stahla-Beek HJ, April DG, Saeedi BJ, Hannah AM, Keenan SM*, Geiss BJ. Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme. J Virol. 2012 86(16):8730-9 Geiss BJ, Stahla-Beek HJ, Hannah AM, Gari HH, Henderson BR, Saeedi BJ, Keenan SM*. A high-throughput screening assay for the identification of flavivirus NS5 capping enzyme GTP-binding inhibitors: implications for antiviral drug development. J Biomol Screen. 2011 Sep;16(8):852-61. Jirage D, Keenan SM, Waters NC. Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases. Infect Disord Drug Targets. 2010 Jun;10(3):134-46. Review. Peng Y, Zhang Q, Arora S, Keenan SM, Kortagere S, Wannemacher KM, Howells, RD and Welsh WJ. Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways. Bioorganic and Medicinal Chemistry. 17(17): 6442-50, 2009 Geyer JA, Keenan SM, Woodard CL, Thompson PA , Gerena L, Nichols DA, Gutteridge CE, and Waters NC. Selective Inhibition of Pfmrk, a Plasmodium falciparum CDK, by Antimalarial 1,3-Diaryl-2-Propenones. Bioorganic & Medicinal Chemistry. 19(7): 1982-5, 2009 Geiss BJ, Stahla H,Hannah MJ, Gari HH and Keenan SM*. Focus on Flaviviruses: Current and Future Drug Targets. Future Medicinal Chemistry. Invited Review. 2 (1): 327-344, 2009 Arora S, Wang XI, Keenan SM, Andaya C, Zhang Q, Peng Y, and Welsh WJ. Novel tubulin polymerization inhibitor with potent antimitotic activity. Cancer Research, .69(5): 1910-5, 2009 Geiss BJ, Thompson AA, Thompson AJ, Sons RL, Gari, HH, Keenan SM and Peersen OB. Analysis of flavivirus NS5 methyltransferase cap binding. Journal of Molecular Biology. 385(5): 1643-54, 2009